Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

Medical News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


September 1st, 2009
Experts Assure That Swine Flu Delays are Under Control

American experts are not convinced that the postponed receipt of the swine flu vaccine will derail the American government’s intention of defending their country against the virus’ recent spread.

Regardless, the government will only receive 45 million doses for October, as opposed to their initial expected amount of 120 million doses, which will, without question, cause stress and concern when it comes to their original vaccination strategy.

Federal health authorities estimate that after mid-October, an increase of 20 million vaccine doses will be made available and shipped each week.  Dr. John Treanor, professor or medicine and microbiology and immunology at the University of Rochester Medical Center in New York City says “The vaccine will undoubtedly be useful … it may not be as useful than if it were ready in September, but I think it will still be useful.”

The vaccine production demands are not only complex but are also vulnerable.  Treanor goes on to attribute the vaccine postponements as a result of the fragile requirements “…making a flu vaccine is a committed process.  There are many steps … and all it takes is for something to be a little bit off … and you are going to see delays or shortages.”

A key issues is the manufacturers’ inability to produce the amounts of dosages originally hoped for.  Treaner clarifies that the vaccine substrate growth is “slower and wimpier,” and “the amount vaccine manufacturers are getting out of millions of eggs is less than expected, and it’s taking longer to make.”

According to the Associated Press, although the government has sent new “seed strains” of the H1N1 virus in an attempt to speed up production, there still remains the an issue of packaging.  The AP, further states that there are not enough manufacturers to package the vaccine.  Fortunately, the government is currently mobilizing additional companies for packaging.

Federal officials have soothed the public’s minds by assuring that there is enough vaccine supply to immunize priority groups.  These groups total roughly 160 million people and include such groups as pregnant women, public health workers and small children.


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930